Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,023 | 18,059 | 44,961 | 11,211 | 13,363 |
| Marketable Securities | 219,701 | 254,747 | 254,069 | 122,894 | 131,469 |
| TOTAL | $245,828 | $279,089 | $306,648 | $138,902 | $147,565 |
| Non-Current Assets | |||||
| PPE Net | 5,852 | 5,131 | 2,163 | 1,910 | 1,672 |
| Other Non-Current Assets | 2,469 | 1,801 | 1,957 | 1,082 | 1,082 |
| TOTAL | $8,321 | $6,932 | $4,121 | $2,993 | $2,754 |
| Total Assets | $254,149 | $286,021 | $310,769 | $141,894 | $150,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,459 | 14,714 | 10,139 | 8,764 | 7,260 |
| Other current liabilities | N/A | N/A | N/A | 276,739 | N/A |
| TOTAL | $15,241 | $16,496 | $11,921 | $287,124 | $8,881 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,782 | 1,782 | 1,782 | 1,622 | 1,622 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 50,112 |
| TOTAL | $8,017 | $8,463 | $8,908 | $8,514 | $59,031 |
| Total Liabilities | $23,258 | $24,959 | $20,829 | $295,638 | $67,913 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,636 | 21,360 | 21,218 | 21,087 | 19,520 |
| Common Shares | 21 | 21 | 21 | 20 | 19 |
| Retained earnings | -469,202 | -434,378 | -398,534 | -443,642 | -185,976 |
| Other shareholders' equity | -283 | -203 | -33 | 44 | 60 |
| TOTAL | $230,891 | $261,062 | $289,940 | $-153,744 | $82,406 |
| Total Liabilities And Equity | $254,149 | $286,021 | $310,769 | $141,894 | $150,319 |